Skip to content

Everyday symptom characterization in adult ADHD using a smartphone and activity tracker

Everyday symptom characterization in adult ADHD using a smartphone and activity tracker - MOSES

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035324
Enrollment
60
Registered
2024-12-19
Start date
2025-02-07
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F90

Interventions

Group 1: Adult patients with ADHD in whom the following parameters are assessed over a period of 14 complete days using two smartphone apps and an activity tracker (EmpaticaEmbrace Plus): Initial ass

Sponsors

Klinik und Poliklinik für Psychiatrie und Psychotherapie Universitätsklinikum Bonn
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: The following inclusion criteria apply to the ADHD group: - Current diagnosis of ADHD according to DSM-V or ICD-10 - Age between 18-55 years - Use of an Android smartphone The following inclusion criteria apply to the control group - Age between 18-55 years - Use of an Android smartphone

Exclusion criteria

Exclusion criteria: The following exclusion criteria apply to the ADHD group: - Taking psychotropic medication (e.g. ADHD medication, antidepressants) - Use of antihypertensive medication or non-topically applied long-term medication - Seizure disorder (epilepsy) or other severe (neurological) illnesses or severe mental disorders such as schizophrenia - pregnancy The following exclusion criteria apply to the control group - mental disorders - No seizure disorders (epilepsy) or other serious (neurological) illnesses - Taking psychotropic medication (e.g. ADHD medication, antidepressants) - Use of antihypertensive medication or non-topically applied long-term medication - Pregnancy

Design outcomes

Primary

MeasureTime frame
All endpoints are checked after 14 days of data collection a) - Heart rate, heart rate variability, steps, activity and movement data, sleep - collected via the Empatica EmbracePlus, aggregated data - data will be examined with regard to the differences between the groups (between-subject) and the time of day (within-subject) b) - Smartphone usage data and context data (number of screen locks, smartphone usage time, usage time for various app categories, brightness during simultaneous smartphone use, volume) - collected via smartphone app - data will be examined with regard to the differences between the groups (between-subject) and the time of day (within-subject) c) - EMA symptom intensity data are analyzed with regard to the differences between the groups (between-subject) and the time of day (within-subject) - collected via smartphone app d) - In addition, the parameters will be compared with regard to the differences in variance between the groups

Secondary

MeasureTime frame
1. The passively collected data will continue to be used to predict the symptom intensity collected via EMA at three times of day. 2. In addition, the data collected over the week will be used to predict the (psychopathological) constructs collected weekly 3. Further exploratory analyses, such as in-depth (among other things based on the raw data) evaluations of sleep data or physical activity data

Countries

Germany

Contacts

Public ContactNiclas Braun

Klinik und Poliklinik für Psychiatrie und Psychotherapie Universitätsklinikum Bonn

niclas.braun@ukbonn.de+49-228-287-31374

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026